首页|期刊导航|Oncology Research|Astragalus polysaccharide enhances the therapeutic efficacy of cisplatin in triple-negative breast cancer through multiple mechanisms

Astragalus polysaccharide enhances the therapeutic efficacy of cisplatin in triple-negative breast cancer through multiple mechanisms

LI SUN SHICHAO ZHUO XIAOXIN LI HUSHENG KONG WEIWEI DU CHONG ZHOU JUNXING HUANG

Oncology Research2025，Vol.33Issue(3)：P.641-651,11.

Oncology Research2025，Vol.33Issue(3)：P.641-651,11.DOI:10.32604/or.2024.050057

Astragalus polysaccharide enhances the therapeutic efficacy of cisplatin in triple-negative breast cancer through multiple mechanisms

LI SUN ¹SHICHAO ZHUO ²XIAOXIN LI ²HUSHENG KONG ³WEIWEI DU ³CHONG ZHOU ⁴JUNXING HUANG¹

作者信息

1. Department of Oncology,Taizhou People’s Hospital Affiliated to Nanjing University of Chinese Medicine,Taizhou,225300,China
2. Department of Pathology,Xuzhou Central Hospital Affiliated to Nanjing University of Chinese Medicine,Xuzhou,221009,China
3. Department of Oncology,Xuzhou Central Hospital Affiliated to Nanjing University of Chinese Medicine,Xuzhou,221009,China
4. Department of Radiotherapy,Xuzhou Central Hospital Affiliated to Nanjing University of Chinese Medicine,Xuzhou,221009,China
折叠

摘要

关键词

Triple-negative breast cancer(TNBC)/Cisplatin(DDP)/Astragalus polysaccharide(APS)/T cell tumor infiltration/Combination treatment

分类

医药卫生

引用本文复制引用

LI SUN,SHICHAO ZHUO,XIAOXIN LI,HUSHENG KONG,WEIWEI DU,CHONG ZHOU,JUNXING HUANG..Astragalus polysaccharide enhances the therapeutic efficacy of cisplatin in triple-negative breast cancer through multiple mechanisms[J].Oncology Research,2025,33(3):P.641-651,11.

基金项目

the Xuzhou Science and Technology Bureau,No.KC23186,Jiangsu Provincial Key Laboratory of New Drug Research and Clinical Pharmacy Project(No.XZSYSKF2023013) （No.XZSYSKF2023013）

Key Medical Disciplines of Jiangsu Province’s 14th Five-Year Plan(ZDXK202237). （ZDXK202237）

Oncology Research

ISSN：0965-0407

访问量0

下载量0

段落导航